PPA
SANA icon

Parametric Portfolio Associates’s Sana Biotechnology SANA Stock Holding History

Parametric Portfolio Associates’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$294K Buy
35,624
+9,863
+38% +$79.7K ﹤0.01% 3290
2021
Q4 		$399K Buy
25,761
+4,966
+24% +$95.7K ﹤0.01% 3157
2021
Q3 		$468K Buy
20,795
+4,809
+30% +$101K ﹤0.01% 3138
2021
Q2 		$314K Buy
+15,986
New +$362K ﹤0.01% 3259

Other funds holding SANA

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Public Sector Pension Investment Board (PSP Investments)
Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $38.7B AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Parametric Portfolio Associates's SANA Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Sana Biotechnology (SANA) stake by 38% in Q1 2022, buying an estimated $79.7K and bringing the position to 35,624 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Parametric Portfolio Associates first reported a position in SANA in Q2 2021 and has held it in 4 quarters since. The position peaked at $468K in Q3 2021. 117 funds tracked by Wall St. Rank hold SANA as of Q1 2022.

  • Parametric Portfolio Associates held 35,624 shares of Sana Biotechnology worth $294K as of Q1 2022.
  • Parametric Portfolio Associates bought 9,863 Sana Biotechnology shares in Q1 2022, an estimated $79.7K.
  • Sana Biotechnology made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3290 holding.
  • Parametric Portfolio Associates first reported a position in Sana Biotechnology in Q2 2021 and has held it in 4 quarters since.
  • Parametric Portfolio Associates's Sana Biotechnology position peaked at $468K in Q3 2021.
  • 117 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.